Search

everythinglearnresearchcommunity

for

Search:↓

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Hair follicle development and microbes help regulatory T cells gather in newborn skin.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Not having enough or having too much of the protein Grainyhead-like 3 leads to various developmental problems.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Changthangi goats have specific genes that help produce Pashmina wool.

Melatonin affects certain genes and pathways involved in cashmere goat hair growth.

PPARγ is essential for maintaining healthy skin, controlling inflammation, and ensuring proper skin barrier function.

Melatonin can increase cashmere yield by altering gene expression and restarting the growth cycle early.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Certain fats in the skin help control inflammation and health, and changing these fats through diet or supplements might treat skin inflammation.

848 genes related to fat and metabolism are less active in people with Central Centrifugal Cicatricial Alopecia.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

Mesenchymal Stem Cell therapy shows promise for treating hair loss in Alopecia Areata.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

HO-1 helps skin health and healing but can worsen melanoma; it's a potential treatment target for skin diseases.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

A new non-invasive method can analyze skin mRNA to understand skin diseases better.

Activating Nrf2 helps wounds heal faster by increasing hair follicle stem cells.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.